1)) Tae K, Lee HS, Seo IS, Lee YS, Cho SH, Choi JH, et al. Hodgkin's and Non-Hodgkin's Lymphoma of Head and Neck. Korean Journal of Otorhinolaryngology-Head and Neck Surgery. 2003;46:324-330.
2)) Al-Hakeem DA, Fedele S, Carlos R, Porter S. Extranodal NK/T-cell lymphoma, nasal type. Oral oncology. 2007;43(1):4-14.
3)) Cho K-J, Cho S-G, Lee D-H. Natural killer T-cell lymphoma of the tongue. Annals of Otology, Rhinology &Laryngology. 2005;114(1):55-57.
4)) Hanna E, Wanamaker J, Adelstein D, Tubbs R, Lavertu P. Extranodal lymphomas of the head and neck:a 20-year experience. Archives of Otolaryngology-Head &Neck Surgery. 1997;123(12):1318-1323.
5)) Li Y-X, Fang H, Liu Q-F, Lu J, Qi S-N, Wang H, et al. Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring. Blood, The Journal of the American Society of Hematology. 2008;112(8):3057-3064.
7)) Tse E, Kwong Y-L. The diagnosis and management of NK/T-cell lymphomas. Journal of hematology &oncology. 2017;10(1):85.
8)) Au W-y, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim W-S, Sng I, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma:a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood, The Journal of the American Society of Hematology. 2009;113(17):3931-3937.
9)) Wu X, Li P, Zhao J, Yang X, Wang F, Yang Y, et al. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type. Clinical Oncology. 2008;20(8):619-625.
10)) Azad FJ, Delavarian Z, Hatami M, Rahimi H, Abdolvahed MR. Extranodal NK/T cell lymphoma with destruction of the uvulae:a case report. Iranian journal of otorhinolaryngology. 2017;29(91):101.
11)) Tlholoe MM, Kotu M, Khammissa RA, Bida M, Lemmer J, Feller L. Extranodal natural killer/T-cell lymphoma, nasal type:'midline lethal granuloma.'A case report. Head &face medicine. 2013;9(1):4.
12)) Li S, Feng X, Li T, Zhang S, Zuo Z, Lin P, et al. Extranodal NK/T-cell lymphoma, nasal type:a report of 73 cases at MD Anderson Cancer Center. The American journal of surgical pathology. 2013;37(1):14-23.
13)) Anderson JR, Armitage JO, Weisenburger DD, Project N-HsLC. Epidemiology of the non-Hodgkin's lymphomas:Distributions of the major subtypes differ by geographic locations. Annals of oncology. 1998;9(7):717-720.
14)) Cheung MM, Chan JK, Wong K-F. Natural killer cell neoplasms:a distinctive group of highly aggressive lymphomas/leukemias. Seminars in hematology. 2003;Elsevier; 221-232.
15)) Kwong Y-L, Kim WS, Lim ST, Kim SJ, Tang T, Tse E, et al. SMILE for natural killer/T-cell lymphoma:analysis of safety and efficacy from the Asia Lymphoma Study Group. Blood, The Journal of the American Society of Hematology. 2012;120(15):2973-2980.
16)) Kim SJ, Yoon SE, Kim WS. Treatment of localized extranodal NK/T cell lymphoma, nasal type:a systematic review. Journal of hematology &oncology. 2018;11(1):140.
17)) Kim GE, Lee S-w, Chang SK, Park HC, Pyo HR, Kim JH, et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiotherapy and Oncology. 2001;61(3):261-269.
18)) Horwitz SM, Ansell SM, Ai WZ, Barnes J, Barta SK, Choi M, et al. NCCN guidelines insights:T-cell lymphomas, version 2.2018. Journal of the National Comprehensive Cancer Network. 2018;16(2):123-135.